Nectar Lifesciences Ltd.

NSE: NECLIFE | BSE: 532649

Nectar Lifesciences Live Share Price Today, Share Analysis and Chart

Mid-range Performer

Iran war impact

Based on the latest financial disclosures and annual reports (up to March 2026), the impact of the Middle East conflict on Nectar Lifesciences Ltd. (NECLIFE) is categorized as Minimal to Indirectly Negative. While the company has a global exp...

10.43 0.01 (0.10%)

New 52W Low today

344.6K

NSE+BSE Volume

NSE 24 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

35.7 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

No estimates available

Nectar Lifesciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Nectar Lifesciences Ltd. worth buying?

176 Votes:

Buy 78.41%

Sell 16.48%

Hold 5.11%